MARKET

GKOS

GKOS

Glaukos Corp
NYSE
177.47
-2.88
-1.60%
After Hours: 179.91 +2.44 +1.38% 19:35 09/04 EDT
OPEN
177.80
PREV CLOSE
180.35
HIGH
181.52
LOW
175.14
VOLUME
572.54K
TURNOVER
--
52 WEEK HIGH
191.62
52 WEEK LOW
73.16
MARKET CAP
10.47B
P/E (TTM)
-54.4353
1D
5D
1M
3M
1Y
5Y
1D
Noteworthy ETF Outflows: SPSM, CORT, GKOS, PAYC
NASDAQ · 1d ago
Analysts Are Bullish on Top Healthcare Stocks: Annovis Bio (ANVS), AbbVie (ABBV)
TipRanks · 1d ago
Chief Development Officer Of Glaukos Sold 28% Of Their Shares
Simply Wall St · 2d ago
Small-cap bears were back. Was IWM the warning sign?
Seeking Alpha · 3d ago
Ten healthcare stocks leading in year-over-year CapEx growth
Seeking Alpha · 3d ago
Top Glaukos Executive Makes Bold Insider Move in High-Value Stock Sale
TipRanks · 3d ago
Glaukos (GKOS) On The iDose TR Narrative And Why Valuation Still Draws Attention
Simply Wall St · 5d ago
Weekly Report: what happened at GKOS last week (0824-0828)?
Weekly Report · 5d ago
More
About GKOS
Glaukos Corporation is an ophthalmic pharmaceutical and medical technology company. The Company is focused on developing and commercializing therapies for the treatment of glaucoma, corneal disorders and retinal diseases. Its commercial solutions and development-stage product candidates include procedural pharmaceuticals based on an intracameral drug delivery technology designed to reduce intraocular pressure (IOP) by delivering therapeutic levels of glaucoma medication from inside the eye over an extended period of time; Micro-Invasive Glaucoma Surgery (MIGS) products that primarily involve the insertion of a micro-scale device designed to reduce IOP by restoring the natural aqueous humor outflow pathways for patients suffering from glaucoma; bio-activated pharmaceuticals that are intended to strengthen, stabilize, and reshape the cornea for patients impacted by corneal ectatic disorders such as keratoconus, among others.

Webull offers Glaukos Corp stock information, including NYSE: GKOS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GKOS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GKOS stock methods without spending real money on the virtual paper trading platform.